ESSA Pharma - ADR Financials

$0.20

$0.00 (-0.10%)

As on 09-Oct-2025 09:30EDT

Market cap

$10 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.1

Div. Yield

87.6 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Cash From Operating Activities	--	-22.72	-19.78	-28.70	-25.42	-16.98
Cash Flow from Investing Activities	--	91.79	-3.53	-52.35	-35.01	-21.74
Cash from Financing Activities	--	0.93	-0.07	0.25	141.99	41.78
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Adjusted EPS ($)	-0.57	-0.64	-0.60	-0.80	-0.90	-0.86
Cash EPS ($)	--	-0.64	-0.60	-0.79	-0.89	-0.85
Adjusted Book Value ($)	--	2.81	3.30	3.79	4.73	2.90
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.51	-0.45	-0.65	-0.62	-0.62
Free Cash Flow per Share ($)	--	-0.51	-0.45	-0.65	-0.62	-0.62

Profitability Ratios	TTM	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
ROCE (%)	--	-21.09	-16.98	-19.41	-26.90	-35.47
ROE (%)	-22.19	-21.12	-17.00	-19.44	-26.94	-36.51
ROA (%)	-20.35	-20.59	-16.69	-19.09	-26.41	-34.64
EBIT Margin (%)	-20,363.00	--	--	--	--	--
Net Margin (%)	-18,611.02	--	--	--	--	--
Cash Profit Margin (%)	-0.21	--	--	--	--	--

Growth Ratios	TTM	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	0.09	-7.41	24.51	4.39	-59.27	-90.22
Net Profit Growth (%)	8.69	-7.38	24.27	4.63	-56.99	-124.55
EPS Growth (%)	9.01	-0.07	0.24	0.11	-0.05	-0.20
Book Value Growth (%)	-15.53	--	--	--	--	--

Valuation Ratios	TTM	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Price / Earnings	--	-9.42	-5.13	-2.29	-8.92	-8.04
Price / Book Value	0.09	2.16	0.94	0.48	1.69	2.38
Dividend Yield (%)	87.56	--	--	--	--	--
EV/EBITDA	-8.09	-5.01	0.44	2.47	-3.64	-4.80
Close Price ($)	1.70	6.06	3.09	1.82	8.00	6.90
High Price ($)	7.88	11.67	5.16	14.88	36.00	8.31
Low Price ($)	1.40	2.65	1.40	1.66	5.40	3.00
Market Cap ($ Cr)	9.52	--	--	--	--	--

Solvency Ratios	TTM	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Debt to Equity	--	0.00	0.00	0.00	0.00	0.00
Short term debt to equity ratio	--	0.00	0.00	0.00	0.00	0.00
Current Ratio	69.07	38.64	42.57	73.38	50.28	66.92
Quick Ratio	69.07	--	--	25.50	--	67.18
Interest Coverage	--	--	-3,827.97	-2,514.38	-1,656.96	-37.40

Operating Efficiency Ratios	TTM	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Debtors to sales (%)	388.31	--	--	--	--	--
Asset Turnover	0.00	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	340,947.97	331,720.68	-1,032.84	-1,109.65
Payable days	--	8,925.29	4,597.36	3,569.62	3,511.08	2,875.67
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.